Spencer Operating Cycle from 2010 to 2026
| SPPH Stock | USD 0.0001 0.00 0.00% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 0.048 | Current Value 0.0456 | Quarterly Volatility 40.9718402 |
Check Spencer Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spencer Pharmaceutical's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 754.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Spencer financial statements analysis is a perfect complement when working with Spencer Pharmaceutical Valuation or Volatility modules.
Spencer | Operating Cycle | Build AI portfolio with Spencer Stock |
The Operating Cycle trend for Spencer Pharmaceutical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Spencer Pharmaceutical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Spencer Pharmaceutical's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Spencer Pharmaceutical over the last few years. It is Spencer Pharmaceutical's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Spencer Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Spencer Operating Cycle Regression Statistics
| Arithmetic Mean | 9.98 | |
| Geometric Mean | 0.07 | |
| Coefficient Of Variation | 410.56 | |
| Mean Deviation | 18.71 | |
| Median | 0.04 | |
| Standard Deviation | 40.97 | |
| Sample Variance | 1,679 | |
| Range | 169 | |
| R-Value | (0.41) | |
| Mean Square Error | 1,492 | |
| R-Squared | 0.17 | |
| Significance | 0.10 | |
| Slope | (3.31) | |
| Total Sum of Squares | 26,859 |
Spencer Operating Cycle History
About Spencer Pharmaceutical Financial Statements
Investors use fundamental indicators, such as Spencer Pharmaceutical's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Spencer Pharmaceutical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 0.05 | 0.05 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Spencer Pharmaceutical Correlation against competitors. For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is there potential for Biotechnology market expansion? Will Spencer introduce new products? Factors like these will boost the valuation of Spencer Pharmaceutical. If investors know Spencer will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Spencer Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spencer Pharmaceutical is measured differently than its book value, which is the value of Spencer that is recorded on the company's balance sheet. Investors also form their own opinion of Spencer Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Spencer Pharmaceutical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Spencer Pharmaceutical's market value can be influenced by many factors that don't directly affect Spencer Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spencer Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spencer Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Spencer Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.